Paired transcriptomics reveals similarities between cytokine-stimulated organoids and ulcerative colitis epithelial responses
Download from source ↗Dataset overview
Patient-matched transcriptomics of in vivo and in vitro colonic epithelium substantiate organoids as a translational model for ulcerative colitis.
Abstract
Ulcerative colitis (UC) is characterized by cytokine-driven inflammation and barrier disruption in the colon, making epithelial dysfunction central to disease pathology. Intestinal epithelial organoids (IEOs) preserve donor-specific genetics and architecture, offering a promising model, but their ability to replicate patient-specific epithelial inflammation remains undetermined. To directly compare in vivo epithelial transcriptional states with defined cytokine-induced responses in vitro, we analyzed patient-matched transcriptomics from laser microdissected inflamed and uninflamed colonic epithelium and IEOs derived from uninflamed biopsies of the same UC patients. IEOs were stimulated with UC-relevant cytokines (TNF, IFNγ, IFNλ1, or TNF + IFNγ) or a cytokine cocktail (TNF, IL17, IL1β, IL22, Poly(I:C), IFNγ). Key inflammatory genes were validated by immunoblotting and immunostaining. Cytokine-stimulated IEOs recapitulated key in vivo epithelial inflammation, including interferon signaling, antigen presentation, and unfolded protein response pathways. Among the tested conditions, TNF + IFNγ combination and the cytokine cocktail most closely replicated UC epithelial inflammation, with concordance for over 350 UC-relevant genes and protein-level validation of IRF1, ERAP2, NOS2, DUOX2 confirmed patient-dependent expression between inflamed epithelium and cytokine-stimulated IEOs. Our study shows that cytokine-stimulated IEOs provide a robust, personalized platform for modeling epithelial inflammation, enabling discovery of epithelial-specific disease mechanisms and therapeutic targets.
doi:10.1038/s41598-026-54857-7 ↗ PMID 42289443 ↗ PMC13527059 ↗
Study facts
- Organism
- Homo sapiens
- Platform
- NovaSeq 6000
- Age group
- —
- Disease groups
- Ulcerative colitis
- Anatomical sites
- —
Data availability
- Analysis code
Strengths & limitations for reuse
Strengths
- Raw reads are advertised
- Analysis code is available
- Participant-to-sample mapping is available
Limitations
- Not documented: feature/otu tables are advertised
- Not documented: taxonomic tables are advertised
- Not documented: participant counts are documented
Extraction evidence & provenance
Each extracted field is shown with the source excerpt and location used to resolve it.
Assay
| Field | Value | Evidence |
|---|---|---|
assay.paired_end |
True |
Paired-end sequencing was performed on the NovaSeq 6000 instrument Section |
assay.platform |
NovaSeq 6000 |
Sequencing was carried out on a NovaSeq6000 platform Section |
assay.read_length |
59 |
using an S2 flowcell for 138 cycles with a 59-10-10–59 bp read configuration Section |
Cohort
| Field | Value | Evidence |
|---|---|---|
cohort.disease_activity_metadata_available |
True |
UC patients with active disease (endoscopic Mayo 2/3) Section |
cohort.ulcerative_colitis_participants |
12 |
the same UC patients (n = 12) Section |
Data_Assets
| Field | Value | Evidence |
|---|---|---|
data_assets.analysis_code |
True |
original code has been deposited at Zenodo and are publicly available Section |
data_assets.open_access |
True |
are accessible through GEO Series accession numbers GSE288617, GSE288517, GSE289072 Section |
data_assets.pipeline_or_tool_versions |
True |
FASTQ files were generated with bcl2fastq2 Conversion Software v2.20.0.422... FastQC (v0.11.9)... fastp (v0.20.1) Section |
data_assets.raw_reads |
True |
The RNA sequencing datasets generated and analyzed during the current study are available in the NCBI's Gene Expression Omnibus (GEO) repository Section |
data_assets.sample_metadata |
True |
All supplementary materials, including data files and detailed metadata descriptions and original code has been deposited at Zenodo Section |
Specimens
| Field | Value | Evidence |
|---|---|---|
specimens.body_site |
colon |
Uninflamed biopsies for laser microdissection and IEO development were acquired from the ascending colon while inflamed biopsies were acquired from an inflamed colonic segment. Section |
specimens.longitudinal_sampling |
True |
Uninflamed biopsies (4–5 per donor) for IEO development were collected from the same patient cohort at 12 months follow-up Section |
specimens.participant_to_sample_mapping_available |
True |
biopsies were simultaneously acquired from the same UC patients Section |
specimens.sample_type |
mucosal_biopsy |
Inflamed and uninflamed biopsies were simultaneously acquired Section |